nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—CA1—esophageal cancer	0.441	0.569	CbGaD
Hydrochlorothiazide—CA2—esophageal cancer	0.334	0.431	CbGaD
Hydrochlorothiazide—KCNMA1—exocrine gland—esophageal cancer	0.00332	0.122	CbGeAlD
Hydrochlorothiazide—CA2—exocrine gland—esophageal cancer	0.00163	0.06	CbGeAlD
Hydrochlorothiazide—KCNMA1—epithelium—esophageal cancer	0.00144	0.053	CbGeAlD
Hydrochlorothiazide—CA9—digestive system—esophageal cancer	0.00142	0.0523	CbGeAlD
Hydrochlorothiazide—KCNMA1—smooth muscle tissue—esophageal cancer	0.00139	0.0511	CbGeAlD
Hydrochlorothiazide—SLC12A3—lung—esophageal cancer	0.00133	0.0487	CbGeAlD
Hydrochlorothiazide—CA4—neck—esophageal cancer	0.00126	0.0463	CbGeAlD
Hydrochlorothiazide—CA12—trachea—esophageal cancer	0.00122	0.045	CbGeAlD
Hydrochlorothiazide—CA12—digestive system—esophageal cancer	0.00105	0.0387	CbGeAlD
Hydrochlorothiazide—CA2—neck—esophageal cancer	0.00104	0.0384	CbGeAlD
Hydrochlorothiazide—KCNMA1—lung—esophageal cancer	0.000916	0.0337	CbGeAlD
Hydrochlorothiazide—CA12—lung—esophageal cancer	0.000879	0.0323	CbGeAlD
Hydrochlorothiazide—CA1—digestive system—esophageal cancer	0.000834	0.0306	CbGeAlD
Hydrochlorothiazide—CA5B—lung—esophageal cancer	0.000788	0.029	CbGeAlD
Hydrochlorothiazide—CA4—trachea—esophageal cancer	0.000757	0.0278	CbGeAlD
Hydrochlorothiazide—CA2—epithelium—esophageal cancer	0.00071	0.0261	CbGeAlD
Hydrochlorothiazide—CA2—bronchus—esophageal cancer	0.000699	0.0257	CbGeAlD
Hydrochlorothiazide—CA1—lung—esophageal cancer	0.000696	0.0256	CbGeAlD
Hydrochlorothiazide—CA2—smooth muscle tissue—esophageal cancer	0.000684	0.0252	CbGeAlD
Hydrochlorothiazide—Bendroflumethiazide—CA1—esophageal cancer	0.000653	0.0757	CrCbGaD
Hydrochlorothiazide—CA4—digestive system—esophageal cancer	0.000651	0.0239	CbGeAlD
Hydrochlorothiazide—CA2—trachea—esophageal cancer	0.000628	0.0231	CbGeAlD
Hydrochlorothiazide—KCNMA1—lymph node—esophageal cancer	0.000627	0.023	CbGeAlD
Hydrochlorothiazide—Quinethazone—CA1—esophageal cancer	0.000598	0.0693	CrCbGaD
Hydrochlorothiazide—Methyclothiazide—CA1—esophageal cancer	0.000573	0.0664	CrCbGaD
Hydrochlorothiazide—Benzthiazide—CA1—esophageal cancer	0.000556	0.0644	CrCbGaD
Hydrochlorothiazide—Cyclothiazide—CA1—esophageal cancer	0.000556	0.0644	CrCbGaD
Hydrochlorothiazide—Chlorothiazide—CA1—esophageal cancer	0.000552	0.0639	CrCbGaD
Hydrochlorothiazide—Diclofenamide—CA1—esophageal cancer	0.000552	0.0639	CrCbGaD
Hydrochlorothiazide—CA4—lung—esophageal cancer	0.000544	0.02	CbGeAlD
Hydrochlorothiazide—CA2—digestive system—esophageal cancer	0.00054	0.0199	CbGeAlD
Hydrochlorothiazide—CA5B—lymph node—esophageal cancer	0.000539	0.0198	CbGeAlD
Hydrochlorothiazide—Bendroflumethiazide—CA2—esophageal cancer	0.000495	0.0574	CrCbGaD
Hydrochlorothiazide—CA1—lymph node—esophageal cancer	0.000476	0.0175	CbGeAlD
Hydrochlorothiazide—Hydroflumethiazide—CA1—esophageal cancer	0.000466	0.054	CrCbGaD
Hydrochlorothiazide—Quinethazone—CA2—esophageal cancer	0.000453	0.0525	CrCbGaD
Hydrochlorothiazide—CA2—lung—esophageal cancer	0.000451	0.0166	CbGeAlD
Hydrochlorothiazide—Methyclothiazide—CA2—esophageal cancer	0.000434	0.0503	CrCbGaD
Hydrochlorothiazide—Cyclothiazide—CA2—esophageal cancer	0.000421	0.0488	CrCbGaD
Hydrochlorothiazide—Benzthiazide—CA2—esophageal cancer	0.000421	0.0488	CrCbGaD
Hydrochlorothiazide—Chlorothiazide—CA2—esophageal cancer	0.000418	0.0484	CrCbGaD
Hydrochlorothiazide—Diclofenamide—CA2—esophageal cancer	0.000418	0.0484	CrCbGaD
Hydrochlorothiazide—Trichlormethiazide—CA1—esophageal cancer	0.000404	0.0468	CrCbGaD
Hydrochlorothiazide—CA4—lymph node—esophageal cancer	0.000372	0.0137	CbGeAlD
Hydrochlorothiazide—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.000357	0.00421	CcSEcCtD
Hydrochlorothiazide—Photosensitivity—Capecitabine—esophageal cancer	0.000356	0.00419	CcSEcCtD
Hydrochlorothiazide—Polyuria—Capecitabine—esophageal cancer	0.000356	0.00419	CcSEcCtD
Hydrochlorothiazide—Swelling—Capecitabine—esophageal cancer	0.000354	0.00417	CcSEcCtD
Hydrochlorothiazide—Hydroflumethiazide—CA2—esophageal cancer	0.000353	0.0409	CrCbGaD
Hydrochlorothiazide—Gastroenteritis—Capecitabine—esophageal cancer	0.000353	0.00415	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Capecitabine—esophageal cancer	0.00035	0.00412	CcSEcCtD
Hydrochlorothiazide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000346	0.00408	CcSEcCtD
Hydrochlorothiazide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000346	0.00407	CcSEcCtD
Hydrochlorothiazide—Libido decreased—Capecitabine—esophageal cancer	0.000337	0.00397	CcSEcCtD
Hydrochlorothiazide—Hot flush—Capecitabine—esophageal cancer	0.000334	0.00394	CcSEcCtD
Hydrochlorothiazide—Increased appetite—Capecitabine—esophageal cancer	0.000333	0.00392	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000331	0.0039	CcSEcCtD
Hydrochlorothiazide—Menopausal symptoms—Capecitabine—esophageal cancer	0.000331	0.0039	CcSEcCtD
Hydrochlorothiazide—Atrial fibrillation—Capecitabine—esophageal cancer	0.00033	0.00388	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Capecitabine—esophageal cancer	0.000329	0.00387	CcSEcCtD
Hydrochlorothiazide—Thirst—Capecitabine—esophageal cancer	0.000329	0.00387	CcSEcCtD
Hydrochlorothiazide—Vasculitis—Methotrexate—esophageal cancer	0.000329	0.00387	CcSEcCtD
Hydrochlorothiazide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000327	0.00384	CcSEcCtD
Hydrochlorothiazide—Purpura—Capecitabine—esophageal cancer	0.000324	0.00382	CcSEcCtD
Hydrochlorothiazide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000322	0.00379	CcSEcCtD
Hydrochlorothiazide—Arthritis—Capecitabine—esophageal cancer	0.000322	0.00379	CcSEcCtD
Hydrochlorothiazide—Renal failure—Cisplatin—esophageal cancer	0.000321	0.00378	CcSEcCtD
Hydrochlorothiazide—Myocardial infarction—Cisplatin—esophageal cancer	0.00032	0.00377	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00032	0.00377	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Cisplatin—esophageal cancer	0.000318	0.00374	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Capecitabine—esophageal cancer	0.000314	0.0037	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000313	0.00368	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Capecitabine—esophageal cancer	0.000313	0.00368	CcSEcCtD
Hydrochlorothiazide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00031	0.00365	CcSEcCtD
Hydrochlorothiazide—CA2—lymph node—esophageal cancer	0.000309	0.0113	CbGeAlD
Hydrochlorothiazide—Migraine—Capecitabine—esophageal cancer	0.000308	0.00362	CcSEcCtD
Hydrochlorothiazide—Trichlormethiazide—CA2—esophageal cancer	0.000306	0.0355	CrCbGaD
Hydrochlorothiazide—Face oedema—Capecitabine—esophageal cancer	0.000302	0.00355	CcSEcCtD
Hydrochlorothiazide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000301	0.00354	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Cisplatin—esophageal cancer	0.000299	0.00352	CcSEcCtD
Hydrochlorothiazide—Mood swings—Capecitabine—esophageal cancer	0.000296	0.00349	CcSEcCtD
Hydrochlorothiazide—Ataxia—Capecitabine—esophageal cancer	0.000294	0.00346	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Capecitabine—esophageal cancer	0.000293	0.00345	CcSEcCtD
Hydrochlorothiazide—Ecchymosis—Methotrexate—esophageal cancer	0.00029	0.00341	CcSEcCtD
Hydrochlorothiazide—Urine output increased—Methotrexate—esophageal cancer	0.00029	0.00341	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Capecitabine—esophageal cancer	0.000289	0.0034	CcSEcCtD
Hydrochlorothiazide—Dry skin—Capecitabine—esophageal cancer	0.000287	0.00337	CcSEcCtD
Hydrochlorothiazide—Abdominal pain upper—Capecitabine—esophageal cancer	0.000286	0.00336	CcSEcCtD
Hydrochlorothiazide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000286	0.00336	CcSEcCtD
Hydrochlorothiazide—Pulmonary oedema—Methotrexate—esophageal cancer	0.000285	0.00336	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Capecitabine—esophageal cancer	0.000285	0.00335	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Cisplatin—esophageal cancer	0.000283	0.00333	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Capecitabine—esophageal cancer	0.000283	0.00333	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000282	0.00331	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000282	0.00331	CcSEcCtD
Hydrochlorothiazide—Gastritis—Capecitabine—esophageal cancer	0.000277	0.00326	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Capecitabine—esophageal cancer	0.000276	0.00325	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000276	0.00325	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Cisplatin—esophageal cancer	0.000274	0.00322	CcSEcCtD
Hydrochlorothiazide—Flushing—Cisplatin—esophageal cancer	0.000272	0.00321	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Capecitabine—esophageal cancer	0.000272	0.0032	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Capecitabine—esophageal cancer	0.00027	0.00318	CcSEcCtD
Hydrochlorothiazide—Influenza—Capecitabine—esophageal cancer	0.00027	0.00318	CcSEcCtD
Hydrochlorothiazide—Diabetes mellitus—Methotrexate—esophageal cancer	0.000268	0.00315	CcSEcCtD
Hydrochlorothiazide—Polyuria—Methotrexate—esophageal cancer	0.000265	0.00312	CcSEcCtD
Hydrochlorothiazide—Photosensitivity—Methotrexate—esophageal cancer	0.000265	0.00312	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Capecitabine—esophageal cancer	0.000263	0.0031	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Cisplatin—esophageal cancer	0.000262	0.00309	CcSEcCtD
Hydrochlorothiazide—Alopecia—Cisplatin—esophageal cancer	0.000259	0.00305	CcSEcCtD
Hydrochlorothiazide—Erythema—Cisplatin—esophageal cancer	0.000255	0.00301	CcSEcCtD
Hydrochlorothiazide—Dysuria—Capecitabine—esophageal cancer	0.000253	0.00298	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Capecitabine—esophageal cancer	0.000253	0.00298	CcSEcCtD
Hydrochlorothiazide—Flatulence—Cisplatin—esophageal cancer	0.000252	0.00296	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000251	0.00296	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000247	0.0029	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000247	0.0029	CcSEcCtD
Hydrochlorothiazide—Weight increased—Capecitabine—esophageal cancer	0.000246	0.0029	CcSEcCtD
Hydrochlorothiazide—Visual disturbance—Methotrexate—esophageal cancer	0.000246	0.00289	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Cisplatin—esophageal cancer	0.000246	0.00289	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Capecitabine—esophageal cancer	0.000244	0.00287	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Capecitabine—esophageal cancer	0.000242	0.00285	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Cisplatin—esophageal cancer	0.000241	0.00283	CcSEcCtD
Hydrochlorothiazide—Tremor—Cisplatin—esophageal cancer	0.000239	0.00282	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000239	0.00281	CcSEcCtD
Hydrochlorothiazide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000238	0.0028	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000237	0.00279	CcSEcCtD
Hydrochlorothiazide—Renal failure—Capecitabine—esophageal cancer	0.000237	0.00279	CcSEcCtD
Hydrochlorothiazide—Myocardial infarction—Capecitabine—esophageal cancer	0.000236	0.00278	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000236	0.00278	CcSEcCtD
Hydrochlorothiazide—Anaemia—Cisplatin—esophageal cancer	0.000236	0.00278	CcSEcCtD
Hydrochlorothiazide—Jaundice—Capecitabine—esophageal cancer	0.000235	0.00277	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Capecitabine—esophageal cancer	0.000234	0.00276	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Capecitabine—esophageal cancer	0.000234	0.00276	CcSEcCtD
Hydrochlorothiazide—Malaise—Cisplatin—esophageal cancer	0.00023	0.00271	CcSEcCtD
Hydrochlorothiazide—Haematuria—Capecitabine—esophageal cancer	0.00023	0.0027	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Cisplatin—esophageal cancer	0.000229	0.00269	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Capecitabine—esophageal cancer	0.000227	0.00268	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Capecitabine—esophageal cancer	0.000225	0.00265	CcSEcCtD
Hydrochlorothiazide—Mood swings—Methotrexate—esophageal cancer	0.000221	0.0026	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Capecitabine—esophageal cancer	0.00022	0.00259	CcSEcCtD
Hydrochlorothiazide—Ataxia—Methotrexate—esophageal cancer	0.000219	0.00258	CcSEcCtD
Hydrochlorothiazide—Myalgia—Cisplatin—esophageal cancer	0.000217	0.00256	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Capecitabine—esophageal cancer	0.000217	0.00255	CcSEcCtD
Hydrochlorothiazide—Anxiety—Cisplatin—esophageal cancer	0.000217	0.00255	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Capecitabine—esophageal cancer	0.000216	0.00255	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Capecitabine—esophageal cancer	0.000215	0.00253	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Methotrexate—esophageal cancer	0.000215	0.00253	CcSEcCtD
Hydrochlorothiazide—Discomfort—Cisplatin—esophageal cancer	0.000215	0.00253	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Capecitabine—esophageal cancer	0.000215	0.00253	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000215	0.00208	CbGpPWpGaD
Hydrochlorothiazide—Oedema peripheral—Capecitabine—esophageal cancer	0.000213	0.00251	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Methotrexate—esophageal cancer	0.00021	0.00248	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00021	0.00247	CcSEcCtD
Hydrochlorothiazide—Oedema—Cisplatin—esophageal cancer	0.000208	0.00245	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000208	0.00245	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Capecitabine—esophageal cancer	0.000208	0.00245	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000205	0.00198	CbGpPWpGaD
Hydrochlorothiazide—Erythema multiforme—Capecitabine—esophageal cancer	0.000205	0.00241	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000204	0.0024	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Cisplatin—esophageal cancer	0.000203	0.0024	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CREBBP—esophageal cancer	0.000203	0.00197	CbGpPWpGaD
Hydrochlorothiazide—Tinnitus—Capecitabine—esophageal cancer	0.000202	0.00237	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Cisplatin—esophageal cancer	0.000202	0.00237	CcSEcCtD
Hydrochlorothiazide—Flushing—Capecitabine—esophageal cancer	0.000201	0.00236	CcSEcCtD
Hydrochlorothiazide—Anorexia—Cisplatin—esophageal cancer	0.000199	0.00234	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Methotrexate—esophageal cancer	0.000197	0.00232	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000196	0.0019	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000196	0.0019	CbGpPWpGaD
Hydrochlorothiazide—Hypotension—Cisplatin—esophageal cancer	0.000195	0.00229	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—HIST1H2BM—esophageal cancer	0.000194	0.00188	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PFN1—esophageal cancer	0.000193	0.00187	CbGpPWpGaD
Hydrochlorothiazide—Arrhythmia—Capecitabine—esophageal cancer	0.000193	0.00227	CcSEcCtD
Hydrochlorothiazide—Alopecia—Capecitabine—esophageal cancer	0.000191	0.00225	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00019	0.00224	CcSEcCtD
Hydrochlorothiazide—Erythema—Capecitabine—esophageal cancer	0.000188	0.00222	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Methotrexate—esophageal cancer	0.000188	0.00221	CcSEcCtD
Hydrochlorothiazide—Dysuria—Methotrexate—esophageal cancer	0.000188	0.00221	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Cisplatin—esophageal cancer	0.000187	0.0022	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000187	0.0022	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Cisplatin—esophageal cancer	0.000186	0.00219	CcSEcCtD
Hydrochlorothiazide—Flatulence—Capecitabine—esophageal cancer	0.000186	0.00218	CcSEcCtD
Hydrochlorothiazide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000185	0.00218	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Capecitabine—esophageal cancer	0.000184	0.00217	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000184	0.00216	CcSEcCtD
Hydrochlorothiazide—Back pain—Capecitabine—esophageal cancer	0.000182	0.00214	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Cisplatin—esophageal cancer	0.000181	0.00213	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Capecitabine—esophageal cancer	0.000181	0.00213	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Methotrexate—esophageal cancer	0.00018	0.00212	CcSEcCtD
Hydrochlorothiazide—Pain—Cisplatin—esophageal cancer	0.000178	0.0021	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000178	0.00172	CbGpPWpGaD
Hydrochlorothiazide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000178	0.00209	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Capecitabine—esophageal cancer	0.000177	0.00209	CcSEcCtD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000177	0.00171	CbGpPWpGaD
Hydrochlorothiazide—Tremor—Capecitabine—esophageal cancer	0.000176	0.00208	CcSEcCtD
Hydrochlorothiazide—Renal failure—Methotrexate—esophageal cancer	0.000176	0.00208	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—BCL2—esophageal cancer	0.000175	0.0017	CbGpPWpGaD
Hydrochlorothiazide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000175	0.00206	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Methotrexate—esophageal cancer	0.000174	0.00205	CcSEcCtD
Hydrochlorothiazide—Anaemia—Capecitabine—esophageal cancer	0.000174	0.00205	CcSEcCtD
Hydrochlorothiazide—Sweating—Methotrexate—esophageal cancer	0.000172	0.00202	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Cisplatin—esophageal cancer	0.000172	0.00202	CcSEcCtD
Hydrochlorothiazide—Haematuria—Methotrexate—esophageal cancer	0.000171	0.00201	CcSEcCtD
Hydrochlorothiazide—Malaise—Capecitabine—esophageal cancer	0.00017	0.002	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Methotrexate—esophageal cancer	0.000169	0.00199	CcSEcCtD
Hydrochlorothiazide—Vertigo—Capecitabine—esophageal cancer	0.000169	0.00199	CcSEcCtD
Hydrochlorothiazide—Syncope—Capecitabine—esophageal cancer	0.000169	0.00199	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Capecitabine—esophageal cancer	0.000169	0.00198	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Methotrexate—esophageal cancer	0.000167	0.00197	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTGS2—esophageal cancer	0.000166	0.00161	CbGpPWpGaD
Hydrochlorothiazide—Palpitations—Capecitabine—esophageal cancer	0.000166	0.00196	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Capecitabine—esophageal cancer	0.000166	0.00195	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Cisplatin—esophageal cancer	0.000165	0.00194	CcSEcCtD
Hydrochlorothiazide—Cough—Capecitabine—esophageal cancer	0.000164	0.00193	CcSEcCtD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000162	0.00156	CbGpPWpGaD
Hydrochlorothiazide—Hepatitis—Methotrexate—esophageal cancer	0.000161	0.0019	CcSEcCtD
Hydrochlorothiazide—Myalgia—Capecitabine—esophageal cancer	0.00016	0.00189	CcSEcCtD
Hydrochlorothiazide—Chest pain—Capecitabine—esophageal cancer	0.00016	0.00189	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Capecitabine—esophageal cancer	0.00016	0.00189	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Methotrexate—esophageal cancer	0.00016	0.00188	CcSEcCtD
Hydrochlorothiazide—Anxiety—Capecitabine—esophageal cancer	0.00016	0.00188	CcSEcCtD
Hydrochlorothiazide—Discomfort—Capecitabine—esophageal cancer	0.000158	0.00186	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Capecitabine—esophageal cancer	0.000157	0.00185	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Hemostasis—CFL1—esophageal cancer	0.000157	0.00152	CbGpPWpGaD
Hydrochlorothiazide—Visual impairment—Methotrexate—esophageal cancer	0.000155	0.00183	CcSEcCtD
Hydrochlorothiazide—Confusional state—Capecitabine—esophageal cancer	0.000155	0.00182	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—BLVRB—esophageal cancer	0.000155	0.0015	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—SLC52A3—esophageal cancer	0.000155	0.0015	CbGpPWpGaD
Hydrochlorothiazide—Oedema—Capecitabine—esophageal cancer	0.000154	0.00181	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Cisplatin—esophageal cancer	0.000154	0.00181	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Methotrexate—esophageal cancer	0.000152	0.00179	CcSEcCtD
Hydrochlorothiazide—Shock—Capecitabine—esophageal cancer	0.000151	0.00178	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Capecitabine—esophageal cancer	0.00015	0.00177	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CCND1—esophageal cancer	0.00015	0.00146	CbGpPWpGaD
Hydrochlorothiazide—Tinnitus—Methotrexate—esophageal cancer	0.00015	0.00177	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Capecitabine—esophageal cancer	0.00015	0.00177	CcSEcCtD
Hydrochlorothiazide—Asthenia—Cisplatin—esophageal cancer	0.00015	0.00176	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000149	0.00144	CbGpPWpGaD
Hydrochlorothiazide—Hyperhidrosis—Capecitabine—esophageal cancer	0.000149	0.00175	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Hemostasis—GNG7—esophageal cancer	0.000148	0.00143	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000148	0.00143	CbGpPWpGaD
Hydrochlorothiazide—Anorexia—Capecitabine—esophageal cancer	0.000146	0.00172	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000145	0.00141	CbGpPWpGaD
Hydrochlorothiazide—Hypotension—Capecitabine—esophageal cancer	0.000144	0.00169	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—BLVRB—esophageal cancer	0.000143	0.00139	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SLC52A3—esophageal cancer	0.000143	0.00139	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Cisplatin—esophageal cancer	0.000143	0.00168	CcSEcCtD
Hydrochlorothiazide—Alopecia—Methotrexate—esophageal cancer	0.000142	0.00168	CcSEcCtD
Hydrochlorothiazide—Erythema—Methotrexate—esophageal cancer	0.00014	0.00165	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00014	0.00165	CcSEcCtD
Hydrochlorothiazide—Insomnia—Capecitabine—esophageal cancer	0.000139	0.00164	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—EP300—esophageal cancer	0.000138	0.00134	CbGpPWpGaD
Hydrochlorothiazide—Paraesthesia—Capecitabine—esophageal cancer	0.000138	0.00162	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Methotrexate—esophageal cancer	0.000137	0.00162	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Capecitabine—esophageal cancer	0.000137	0.00161	CcSEcCtD
Hydrochlorothiazide—Back pain—Methotrexate—esophageal cancer	0.000136	0.0016	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Capecitabine—esophageal cancer	0.000135	0.00159	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000135	0.00131	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—NOS2—esophageal cancer	0.000135	0.0013	CbGpPWpGaD
Hydrochlorothiazide—Decreased appetite—Capecitabine—esophageal cancer	0.000134	0.00157	CcSEcCtD
Hydrochlorothiazide—Vomiting—Cisplatin—esophageal cancer	0.000133	0.00156	CcSEcCtD
Hydrochlorothiazide—Fatigue—Capecitabine—esophageal cancer	0.000133	0.00156	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Methotrexate—esophageal cancer	0.000132	0.00156	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—SLC10A2—esophageal cancer	0.000132	0.00128	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CA1—esophageal cancer	0.000132	0.00128	CbGpPWpGaD
Hydrochlorothiazide—Rash—Cisplatin—esophageal cancer	0.000131	0.00155	CcSEcCtD
Hydrochlorothiazide—Pain—Capecitabine—esophageal cancer	0.000131	0.00155	CcSEcCtD
Hydrochlorothiazide—Constipation—Capecitabine—esophageal cancer	0.000131	0.00155	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Cisplatin—esophageal cancer	0.000131	0.00155	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00013	0.00153	CcSEcCtD
Hydrochlorothiazide—Anaemia—Methotrexate—esophageal cancer	0.00013	0.00153	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Capecitabine—esophageal cancer	0.000127	0.00149	CcSEcCtD
Hydrochlorothiazide—Malaise—Methotrexate—esophageal cancer	0.000126	0.00149	CcSEcCtD
Hydrochlorothiazide—Vertigo—Methotrexate—esophageal cancer	0.000126	0.00148	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000126	0.00148	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Methotrexate—esophageal cancer	0.000125	0.00148	CcSEcCtD
Hydrochlorothiazide—Nausea—Cisplatin—esophageal cancer	0.000124	0.00146	CcSEcCtD
Hydrochlorothiazide—Cough—Methotrexate—esophageal cancer	0.000122	0.00144	CcSEcCtD
Hydrochlorothiazide—Urticaria—Capecitabine—esophageal cancer	0.000122	0.00144	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—CA1—esophageal cancer	0.000122	0.00118	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—SLC10A2—esophageal cancer	0.000122	0.00118	CbGpPWpGaD
Hydrochlorothiazide—Body temperature increased—Capecitabine—esophageal cancer	0.000121	0.00143	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Capecitabine—esophageal cancer	0.000121	0.00143	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MYC—esophageal cancer	0.000121	0.00117	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HSPA5—esophageal cancer	0.00012	0.00117	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CA2—esophageal cancer	0.00012	0.00117	CbGpPWpGaD
Hydrochlorothiazide—Chest pain—Methotrexate—esophageal cancer	0.000119	0.0014	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Methotrexate—esophageal cancer	0.000119	0.0014	CcSEcCtD
Hydrochlorothiazide—Myalgia—Methotrexate—esophageal cancer	0.000119	0.0014	CcSEcCtD
Hydrochlorothiazide—Discomfort—Methotrexate—esophageal cancer	0.000118	0.00139	CcSEcCtD
Hydrochlorothiazide—Confusional state—Methotrexate—esophageal cancer	0.000115	0.00136	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000114	0.00135	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—SLC52A3—esophageal cancer	0.000114	0.00111	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—BLVRB—esophageal cancer	0.000114	0.00111	CbGpPWpGaD
Hydrochlorothiazide—Hypersensitivity—Capecitabine—esophageal cancer	0.000113	0.00133	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000112	0.00132	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—PLCE1—esophageal cancer	0.000112	0.00108	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ADH7—esophageal cancer	0.000112	0.00108	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CA2—esophageal cancer	0.000112	0.00108	CbGpPWpGaD
Hydrochlorothiazide—Hyperhidrosis—Methotrexate—esophageal cancer	0.000111	0.0013	CcSEcCtD
Hydrochlorothiazide—Asthenia—Capecitabine—esophageal cancer	0.00011	0.0013	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—BLVRB—esophageal cancer	0.00011	0.00106	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SLC52A3—esophageal cancer	0.00011	0.00106	CbGpPWpGaD
Hydrochlorothiazide—Anorexia—Methotrexate—esophageal cancer	0.000109	0.00128	CcSEcCtD
Hydrochlorothiazide—Pruritus—Capecitabine—esophageal cancer	0.000109	0.00128	CcSEcCtD
Hydrochlorothiazide—Hypotension—Methotrexate—esophageal cancer	0.000107	0.00126	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Capecitabine—esophageal cancer	0.000105	0.00124	CcSEcCtD
Hydrochlorothiazide—CA1—Metabolism—SLC52A3—esophageal cancer	0.000105	0.00102	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—BLVRB—esophageal cancer	0.000105	0.00102	CbGpPWpGaD
Hydrochlorothiazide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000104	0.00123	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—SOD2—esophageal cancer	0.000104	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ADH7—esophageal cancer	0.000104	0.001	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PLCE1—esophageal cancer	0.000104	0.001	CbGpPWpGaD
Hydrochlorothiazide—Insomnia—Methotrexate—esophageal cancer	0.000103	0.00122	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Methotrexate—esophageal cancer	0.000103	0.00121	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Methotrexate—esophageal cancer	0.000102	0.0012	CcSEcCtD
Hydrochlorothiazide—Somnolence—Methotrexate—esophageal cancer	0.000102	0.0012	CcSEcCtD
Hydrochlorothiazide—Dizziness—Capecitabine—esophageal cancer	0.000102	0.0012	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Methotrexate—esophageal cancer	0.000101	0.00119	CcSEcCtD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000101	0.000975	CbGpPWpGaD
Hydrochlorothiazide—Decreased appetite—Methotrexate—esophageal cancer	9.95e-05	0.00117	CcSEcCtD
Hydrochlorothiazide—Fatigue—Methotrexate—esophageal cancer	9.86e-05	0.00116	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—ADH1B—esophageal cancer	9.82e-05	0.000951	CbGpPWpGaD
Hydrochlorothiazide—Pain—Methotrexate—esophageal cancer	9.78e-05	0.00115	CcSEcCtD
Hydrochlorothiazide—Vomiting—Capecitabine—esophageal cancer	9.77e-05	0.00115	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—CA1—esophageal cancer	9.73e-05	0.000942	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—SLC10A2—esophageal cancer	9.73e-05	0.000942	CbGpPWpGaD
Hydrochlorothiazide—Rash—Capecitabine—esophageal cancer	9.69e-05	0.00114	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Capecitabine—esophageal cancer	9.68e-05	0.00114	CcSEcCtD
Hydrochlorothiazide—Headache—Capecitabine—esophageal cancer	9.63e-05	0.00113	CcSEcCtD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.47e-05	0.000917	CbGpPWpGaD
Hydrochlorothiazide—Feeling abnormal—Methotrexate—esophageal cancer	9.43e-05	0.00111	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—TYMP—esophageal cancer	9.38e-05	0.000909	CbGpPWpGaD
Hydrochlorothiazide—Gastrointestinal pain—Methotrexate—esophageal cancer	9.36e-05	0.0011	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—CA1—esophageal cancer	9.33e-05	0.000904	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—SLC10A2—esophageal cancer	9.33e-05	0.000904	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SLC52A3—esophageal cancer	9.24e-05	0.000896	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—BLVRB—esophageal cancer	9.24e-05	0.000896	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Capecitabine—esophageal cancer	9.13e-05	0.00107	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—CYP26A1—esophageal cancer	9.13e-05	0.000884	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ADH1B—esophageal cancer	9.09e-05	0.000881	CbGpPWpGaD
Hydrochlorothiazide—Urticaria—Methotrexate—esophageal cancer	9.09e-05	0.00107	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Methotrexate—esophageal cancer	9.04e-05	0.00106	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Methotrexate—esophageal cancer	9.04e-05	0.00106	CcSEcCtD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.97e-05	0.000869	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—SLC10A2—esophageal cancer	8.94e-05	0.000866	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—ABL1—esophageal cancer	8.92e-05	0.000865	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CA2—esophageal cancer	8.9e-05	0.000862	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ALOX15—esophageal cancer	8.89e-05	0.000862	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—HIF1A—esophageal cancer	8.75e-05	0.000848	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—TYMP—esophageal cancer	8.69e-05	0.000842	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.56e-05	0.000829	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTO1—esophageal cancer	8.48e-05	0.000822	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—TPI1—esophageal cancer	8.48e-05	0.000822	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP26A1—esophageal cancer	8.45e-05	0.000819	CbGpPWpGaD
Hydrochlorothiazide—Hypersensitivity—Methotrexate—esophageal cancer	8.43e-05	0.000992	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—PLCE1—esophageal cancer	8.27e-05	0.000801	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ADH7—esophageal cancer	8.27e-05	0.000801	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ALOX15—esophageal cancer	8.24e-05	0.000798	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—EP300—esophageal cancer	8.23e-05	0.000798	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.22e-05	0.000797	CbGpPWpGaD
Hydrochlorothiazide—Asthenia—Methotrexate—esophageal cancer	8.21e-05	0.000966	CcSEcCtD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.21e-05	0.000795	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.21e-05	0.000795	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CA2—esophageal cancer	8.18e-05	0.000792	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ALDOB—esophageal cancer	8.13e-05	0.000788	CbGpPWpGaD
Hydrochlorothiazide—Pruritus—Methotrexate—esophageal cancer	8.09e-05	0.000953	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—ADH7—esophageal cancer	7.93e-05	0.000768	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PLCE1—esophageal cancer	7.93e-05	0.000768	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.89e-05	0.000765	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CA1—esophageal cancer	7.86e-05	0.000762	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—SLC10A2—esophageal cancer	7.86e-05	0.000762	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTO1—esophageal cancer	7.86e-05	0.000762	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—TPI1—esophageal cancer	7.86e-05	0.000762	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GAPDH—esophageal cancer	7.83e-05	0.000759	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Methotrexate—esophageal cancer	7.83e-05	0.000922	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—CRABP1—esophageal cancer	7.76e-05	0.000752	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PLCE1—esophageal cancer	7.6e-05	0.000737	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ADH7—esophageal cancer	7.6e-05	0.000737	CbGpPWpGaD
Hydrochlorothiazide—Dizziness—Methotrexate—esophageal cancer	7.57e-05	0.000891	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—ALDOB—esophageal cancer	7.54e-05	0.00073	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GNG7—esophageal cancer	7.38e-05	0.000715	CbGpPWpGaD
Hydrochlorothiazide—Vomiting—Methotrexate—esophageal cancer	7.27e-05	0.000856	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—GAPDH—esophageal cancer	7.25e-05	0.000703	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ADH1B—esophageal cancer	7.25e-05	0.000703	CbGpPWpGaD
Hydrochlorothiazide—Rash—Methotrexate—esophageal cancer	7.21e-05	0.000849	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Methotrexate—esophageal cancer	7.21e-05	0.000848	CcSEcCtD
Hydrochlorothiazide—CA9—Metabolism—CA2—esophageal cancer	7.19e-05	0.000697	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CRABP1—esophageal cancer	7.19e-05	0.000697	CbGpPWpGaD
Hydrochlorothiazide—Headache—Methotrexate—esophageal cancer	7.17e-05	0.000844	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—CREBBP—esophageal cancer	7.15e-05	0.000693	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—RB1—esophageal cancer	7.12e-05	0.00069	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ADH1B—esophageal cancer	6.95e-05	0.000674	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TYMP—esophageal cancer	6.93e-05	0.000672	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ALDH2—esophageal cancer	6.92e-05	0.00067	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GNG7—esophageal cancer	6.84e-05	0.000663	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Methotrexate—esophageal cancer	6.8e-05	0.0008	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—CYP26A1—esophageal cancer	6.74e-05	0.000653	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PLCE1—esophageal cancer	6.68e-05	0.000648	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ADH7—esophageal cancer	6.68e-05	0.000648	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ADH1B—esophageal cancer	6.67e-05	0.000646	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TYMP—esophageal cancer	6.64e-05	0.000644	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTT1—esophageal cancer	6.58e-05	0.000637	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ALOX15—esophageal cancer	6.57e-05	0.000637	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP2A6—esophageal cancer	6.5e-05	0.00063	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP26A1—esophageal cancer	6.46e-05	0.000626	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—NOS2—esophageal cancer	6.43e-05	0.000623	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ALDH2—esophageal cancer	6.41e-05	0.000621	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TYMP—esophageal cancer	6.37e-05	0.000617	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ALOX15—esophageal cancer	6.3e-05	0.00061	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TPI1—esophageal cancer	6.27e-05	0.000607	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTO1—esophageal cancer	6.27e-05	0.000607	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN2A—esophageal cancer	6.26e-05	0.000607	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.22e-05	0.000603	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP26A1—esophageal cancer	6.2e-05	0.0006	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ENO1—esophageal cancer	6.16e-05	0.000597	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS1—esophageal cancer	6.16e-05	0.000597	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTT1—esophageal cancer	6.09e-05	0.000591	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PSME1—esophageal cancer	6.07e-05	0.000589	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PSME2—esophageal cancer	6.07e-05	0.000589	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ALOX15—esophageal cancer	6.04e-05	0.000585	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP2A6—esophageal cancer	6.02e-05	0.000584	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ALDOB—esophageal cancer	6.01e-05	0.000582	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTO1—esophageal cancer	6.01e-05	0.000582	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TPI1—esophageal cancer	6.01e-05	0.000582	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—esophageal cancer	5.89e-05	0.000571	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ADH1B—esophageal cancer	5.86e-05	0.000568	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GAPDH—esophageal cancer	5.78e-05	0.00056	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—CREBBP—esophageal cancer	5.78e-05	0.00056	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TPI1—esophageal cancer	5.76e-05	0.000558	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTO1—esophageal cancer	5.76e-05	0.000558	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ALDOB—esophageal cancer	5.76e-05	0.000558	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CRABP1—esophageal cancer	5.73e-05	0.000555	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ENO1—esophageal cancer	5.71e-05	0.000553	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS1—esophageal cancer	5.71e-05	0.000553	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.64e-05	0.000547	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PSME1—esophageal cancer	5.63e-05	0.000545	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PSME2—esophageal cancer	5.63e-05	0.000545	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TYMP—esophageal cancer	5.6e-05	0.000543	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GAPDH—esophageal cancer	5.55e-05	0.000537	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ALDOB—esophageal cancer	5.52e-05	0.000535	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CRABP1—esophageal cancer	5.5e-05	0.000533	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GNG7—esophageal cancer	5.45e-05	0.000528	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP26A1—esophageal cancer	5.45e-05	0.000528	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GAPDH—esophageal cancer	5.32e-05	0.000515	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ALOX15—esophageal cancer	5.31e-05	0.000514	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.27e-05	0.000511	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CRABP1—esophageal cancer	5.27e-05	0.000511	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP1B1—esophageal cancer	5.24e-05	0.000508	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GNG7—esophageal cancer	5.23e-05	0.000507	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—NOS3—esophageal cancer	5.17e-05	0.000501	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	5.12e-05	0.000496	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ALDH2—esophageal cancer	5.11e-05	0.000495	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTO1—esophageal cancer	5.06e-05	0.000491	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TPI1—esophageal cancer	5.06e-05	0.000491	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GNG7—esophageal cancer	5.01e-05	0.000486	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP19A1—esophageal cancer	4.93e-05	0.000477	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ALDH2—esophageal cancer	4.9e-05	0.000475	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—EP300—esophageal cancer	4.87e-05	0.000472	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTT1—esophageal cancer	4.86e-05	0.000471	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ALDOB—esophageal cancer	4.86e-05	0.00047	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP1B1—esophageal cancer	4.86e-05	0.00047	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP2A6—esophageal cancer	4.8e-05	0.000465	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ALDH2—esophageal cancer	4.7e-05	0.000455	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GAPDH—esophageal cancer	4.67e-05	0.000453	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTT1—esophageal cancer	4.66e-05	0.000451	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CRABP1—esophageal cancer	4.63e-05	0.000449	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP2A6—esophageal cancer	4.61e-05	0.000446	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP19A1—esophageal cancer	4.57e-05	0.000442	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS1—esophageal cancer	4.55e-05	0.000441	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ENO1—esophageal cancer	4.55e-05	0.000441	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—HMOX1—esophageal cancer	4.5e-05	0.000436	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PSME1—esophageal cancer	4.49e-05	0.000435	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PSME2—esophageal cancer	4.49e-05	0.000435	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTT1—esophageal cancer	4.47e-05	0.000433	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP2A6—esophageal cancer	4.42e-05	0.000428	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GNG7—esophageal cancer	4.41e-05	0.000427	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ENO1—esophageal cancer	4.37e-05	0.000423	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS1—esophageal cancer	4.37e-05	0.000423	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ABCB1—esophageal cancer	4.32e-05	0.000418	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PSME1—esophageal cancer	4.3e-05	0.000417	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PSME2—esophageal cancer	4.3e-05	0.000417	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ENO1—esophageal cancer	4.19e-05	0.000406	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS1—esophageal cancer	4.19e-05	0.000406	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—HMOX1—esophageal cancer	4.17e-05	0.000404	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ALDH2—esophageal cancer	4.13e-05	0.0004	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PSME2—esophageal cancer	4.12e-05	0.0004	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PSME1—esophageal cancer	4.12e-05	0.0004	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ABCB1—esophageal cancer	4e-05	0.000387	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—EP300—esophageal cancer	3.93e-05	0.000381	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTT1—esophageal cancer	3.93e-05	0.000381	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP2A6—esophageal cancer	3.88e-05	0.000376	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP1B1—esophageal cancer	3.87e-05	0.000375	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP1B1—esophageal cancer	3.71e-05	0.00036	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ENO1—esophageal cancer	3.68e-05	0.000357	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS1—esophageal cancer	3.68e-05	0.000357	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP19A1—esophageal cancer	3.64e-05	0.000353	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PSME1—esophageal cancer	3.63e-05	0.000351	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PSME2—esophageal cancer	3.63e-05	0.000351	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP1B1—esophageal cancer	3.56e-05	0.000345	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP19A1—esophageal cancer	3.49e-05	0.000338	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—esophageal cancer	3.48e-05	0.000338	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.44e-05	0.000333	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP19A1—esophageal cancer	3.35e-05	0.000324	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—HMOX1—esophageal cancer	3.32e-05	0.000322	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.3e-05	0.00032	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ABCB1—esophageal cancer	3.19e-05	0.000309	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—HMOX1—esophageal cancer	3.19e-05	0.000309	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP1B1—esophageal cancer	3.13e-05	0.000303	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ABCB1—esophageal cancer	3.06e-05	0.000296	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—HMOX1—esophageal cancer	3.05e-05	0.000296	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP19A1—esophageal cancer	2.94e-05	0.000285	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ABCB1—esophageal cancer	2.93e-05	0.000284	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CA—esophageal cancer	2.91e-05	0.000282	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CREBBP—esophageal cancer	2.88e-05	0.00028	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—esophageal cancer	2.82e-05	0.000273	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—HMOX1—esophageal cancer	2.68e-05	0.00026	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CREBBP—esophageal cancer	2.67e-05	0.000259	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NOS3—esophageal cancer	2.58e-05	0.00025	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ABCB1—esophageal cancer	2.58e-05	0.00025	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NOS3—esophageal cancer	2.39e-05	0.000232	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS2—esophageal cancer	2.36e-05	0.000229	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.21e-05	0.000214	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS2—esophageal cancer	2.19e-05	0.000212	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CREBBP—esophageal cancer	2.13e-05	0.000206	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CREBBP—esophageal cancer	2.04e-05	0.000198	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—EP300—esophageal cancer	1.96e-05	0.00019	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CREBBP—esophageal cancer	1.96e-05	0.00019	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NOS3—esophageal cancer	1.91e-05	0.000185	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NOS3—esophageal cancer	1.83e-05	0.000177	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—EP300—esophageal cancer	1.82e-05	0.000176	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NOS3—esophageal cancer	1.75e-05	0.00017	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS2—esophageal cancer	1.75e-05	0.000169	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CREBBP—esophageal cancer	1.72e-05	0.000167	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS2—esophageal cancer	1.67e-05	0.000162	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS2—esophageal cancer	1.6e-05	0.000155	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NOS3—esophageal cancer	1.54e-05	0.000149	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.45e-05	0.000141	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—EP300—esophageal cancer	1.45e-05	0.000141	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS2—esophageal cancer	1.41e-05	0.000137	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—EP300—esophageal cancer	1.39e-05	0.000135	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CA—esophageal cancer	1.35e-05	0.00013	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—EP300—esophageal cancer	1.33e-05	0.000129	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—EP300—esophageal cancer	1.17e-05	0.000114	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CA—esophageal cancer	1.07e-05	0.000104	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CA—esophageal cancer	1.03e-05	9.97e-05	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CA—esophageal cancer	9.87e-06	9.56e-05	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CA—esophageal cancer	8.68e-06	8.41e-05	CbGpPWpGaD
